Lupin Q3 PAT seen up 4% to Rs 233 crPublished on Tue, Jan 24, 2012 at 10:00 | Source : CNBC-TV18 Updated at Tue, Jan 24, 2012 at 10:04
Lupin is expected to report a profit after tax of Rs 233 crore in the quarter ended December FY12, a moderate growth of 4% as compared to Rs 224 crore in a year ago quarter. Revenues are seen going up by 15% to Rs 1,730 crore from Rs 1,510 crore year-on-year. EBITDA is likely to go up by 8.2% to Rs 321.7 crore in the third quarter of FY12 versus Rs 297.3 crore in the corresponding quarter of last fiscal. Operating profit margin is expected to be at 18.6% versus 19.7% year-on-year and 22.8% QoQ. On quarter-on-quarter basis, revenues are likely to fall 2.4% and profit after tax is seen going down 13%. Watch out for > Revenues to be driven via India + Export formulation > In Q2 formulation grew 28% to Rs 1588 crore (US+ Europe up 8% to Rs 694 crore and Japan up 14% to Rs 178 cr) > US to accelerate versus earlier 4 quarters via key launches such as Femcon Fe, Keppra and LoSeasonique >Semi Regulated markets to continue growth trend (grew 35% YoY to Rs 160 crore) >Expect 20% + growth in India - due to chronic segment + addition of Eli Lilly s Insulin Franchise (Rs 27 crore expected) > Watch out for API which could be flat to decline in Q2 API was flat at Rs 195 crore > Margins to be in the same range but adverse currency movement could affect it (USD 200 million hedged @ Rs 46) > 20 to 25% guidance in FY12 for Lupin and margins of 20%+
PREVIOUS STORY Trending NewsBusiness News
|
NewsVideos
May 29 2012, 12:19 Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart - in Brokerage Results Estimates Interviews
![]() May 29 2012, 22:37 | Source: CNBC-TV18 ![]() May 29 2012, 17:34 | Source: CNBC-TV18 ![]() Subscribe to Moneycontrol Newsletters |
|||||||